Absci Corp. (ABSI)
3.93
+0.41
(+11.65%)
USD |
NASDAQ |
Dec 10, 14:54
Absci EPS Diluted (Quarterly): -0.1997 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Verastem, Inc. | -1.347 |
| Fortress Biotech, Inc. | 0.111 |
| Anavex Life Sciences Corp. | -0.1144 |
| Ocugen, Inc. | -0.066 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.71M |
| Revenue (Quarterly) | 0.378M |
| Total Expenses (Quarterly) | 29.08M |
| Enterprise Value | 366.71M |
| Gross Profit Margin (Quarterly) | -651.9% |
| Profit Margin (Quarterly) | -7.59K% |
| Earnings Yield | -23.01% |
| Normalized Earnings Yield | -23.01 |